| HOME >> BIOLOGY >> TECHNOLOGY |
Net Sales 183,303 99.4% 181,819 99.5%
Other Revenues 1,792 1.0% 864 0.5%
Net Revenue 185,095 100.4% 182,683 100.0%
Cost of Sales 127,120 69.0% 115,829 63.4%
Gross Profit 57,975 31.4% 66,854 36.6%
Operating Expenses
Selling, General and
Administrative Expenses 31,511 17.0% 36,572 20.1%
Research and Development Expenses 5,945 3.2% 8,623 4.7%
Restructuring Expenses 1,469 0.8% 4,034 2.2%
Strategic Alternative Costs 1,408 0.8% 28,560 15.6%
Total Operating Expenses 40,333 21.8% 77,789 42.6%
Operating Profit/(Loss) 17,642 9.6% (10,935) -6.0%
Other Expenses/(Income):
Interest Expense/(Income), net 2,302 1.3% (1,341) -0.7%
Other Expenses, net 459 0.2% 930 0.5%
Income/(Loss) Before Income Taxes 14,881 8.1% (10,524) -5.8%
Provision for Income Taxes 6,002 3.3% 4,200 2.3%
Income/(Loss) from Continuing
Operations $8,879 4.8% $(14,724) -8.1%
Income from Discontinued
Operations, Net of Tax - 0.0% 223,707 122.4%
Net Income $8,879 4.8% $208,983 114.3%
Basic Earnings/(Loss) per Share
Income/(Loss) from Continuing
Operations $0.31 $(0.52)
Income from Discontinued
Operations, Net of Tax $- $7.83
Net Income $0.31
'/>"/>
| SOURCE Cambrex Corporation Copyright©2008 PR Newswire. All rights reserved |